Shares Homepage - BSE Sensex, NSE Nifty, Latest Prices, Live News, Company Search, Result Annoucements, Company News, Top stories, Gainers Losers, Top Performers, Market Commentary, Live Quotes, Bulk Deals
Credit Analysis & Research (CARE) reaffirmed 'AA-' ratings to Wockhardt's long term bank facilities of Rs 2.95 billion.
Wockhardt disclosed a steep drop in consolidated net profit for the quarter ended December 2013. During the quarter, the profit of the company declined 28.84% to Rs 3,044.50 million from Rs 4,278.40 million in the same quarter previous year.
Emerging Markets Sudan Free Equity Index Fund has sol... More..
Wockhardt Ltd is exploring possibilities of co-licensing WCK-771 and WCK-919. The company intends to focus essentially on the anti-infective therapeutic segment as it accounts for 12 per cent of the total pharma market and is the third largest therapeutic segment. Habil Khorakiwala